Butterfly Network Expands Handheld Ultrasound into Brazil

What happened

Butterfly Network announced commercial availability of its iQ+ and iQ3 handheld ultrasound devices in Brazil, the largest medical device market in Latin America, through authorized distribution partners. This expansion aligns with the company's strategy to increase international reach and drive revenue growth, which the DeepValue report estimates at $82.1 million in 2024 and a mid-to-high $90 million outlook for 2025. However, the report maintains a HOLD rating, citing that Butterfly remains loss-making with a net loss of $13.8 million in Q2 2025 and gross profit ($14.9 million) still trailing operating expenses ($31.0 million). The Brazil move adds a new growth avenue but does not alter the fundamental challenge of converting enterprise pilots into scaled, higher-margin software-led contracts amid intense competition from GE, Philips, and Fujifilm. While the expansion is a positive tactical step, the path to profitability and cash flow independence remains unproven, and execution risks persist.

Implication

The Brazil launch provides a new revenue stream in a high-growth ultrasound market, but the DeepValue report underscores that Butterfly's core thesis hinges on enterprise software attach, AI adoption, and gross margin improvement, not just device sales. The company is still burning cash (net loss of $13.8M in Q2 2025) and faces entrenched incumbents. Investors should monitor whether this international push translates into higher software/services mix and ARPU, or if it dilutes focus. Near-term, the stock may see a slight positive reaction, but the HOLD stance remains appropriate until there is clear evidence of operating leverage and a credible path to breakeven. A sustained enterprise win rate and improving unit economics would be the catalysts to turn more constructive.

Thesis delta

The Brazil expansion is a incremental positive for revenue growth but does not alter the core thesis. The DeepValue report's HOLD rating remains justified as profitability and competitive dynamics are unchanged. The move adds optionality but does not resolve the key uncertainties around software monetization and cash flow independence.